The B-BEAM and R-BEAM regimens produced similar 2-year PFS and OS rates for patients with chemotherapy-sensitive relapsed DLBCL. No differences in toxicities...
Learn about carmustine (BiCNU) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives.